MiaMed Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
MiaMed General Information
Description
Developer of brain disorder medicines. The company provides research and development services for cyclin-dependent kinase-like 5 focused on treatment of brain disorders.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
- 641 Lexington Avenue
- 15th Floor
- New York, NY 10022
- United States
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Acquirer
Vertical(s)
Corporate Office
- 641 Lexington Avenue
- 15th Floor
- New York, NY 10022
- United States
MiaMed Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
MiaMed FAQs
-
Where is MiaMed headquartered?
MiaMed is headquartered in New York, NY.
-
What industry is MiaMed in?
MiaMed’s primary industry is Buildings and Property.
-
Is MiaMed a private or public company?
MiaMed is a Private company.
-
What is the current valuation of MiaMed?
The current valuation of MiaMed is .
-
What is MiaMed’s current revenue?
The current revenue for MiaMed is .
-
When was MiaMed acquired?
MiaMed was acquired on 05-Jul-2016.
-
Who acquired MiaMed?
MiaMed was acquired by Amicus Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process